<DOC>
	<DOC>NCT00263874</DOC>
	<brief_summary>This initial proof of concept, phase II study aims to assess the safety and efficacy of UK-500,001 for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease.</brief_summary>
	<brief_title>Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Moderatesevere COPD (Global inititiative for chronic Obstructive Lung Disease, GOLD, 2003 definition) Smoking history of at least 10 packyears Any significant comorbid disease Use of any maintenance therapy except short acting bronchodilators</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>